111 related articles for article (PubMed ID: 31560814)
1. Exploration of 5-(5-nitrothiophen-2-yl)-4,5-dihydro-1H-pyrazoles as selective, multitargeted antimycobacterial agents.
Agre N; Khambete M; Maitra A; Gupta A; Munshi T; Bhakta S; Degani M
Chem Biol Drug Des; 2020 Jan; 95(1):192-199. PubMed ID: 31560814
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and mycobacterial evaluation of 5-substituted-6-acetyl-2-amino-7-methyl-5,8-dihydropyrido-[2,3-d]pyrimidin-4(3H)-one derivatives.
Agre N; Degani M; Gupta A; Bhakta S; Ray MK
Arch Pharm (Weinheim); 2019 Sep; 352(9):e1900068. PubMed ID: 31339194
[TBL] [Abstract][Full Text] [Related]
3. 3-(5-Nitrofuran-2-yl)prop-2-en-1-one Derivatives, with Potent Antituberculosis Activity, Inhibit A Novel Therapeutic Target, Arylamine
Agre N; Tawari N; Maitra A; Gupta A; Munshi T; Degani M; Bhakta S
Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32630175
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.
Fullam E; Talbot J; Abuhammed A; Westwood I; Davies SG; Russell AJ; Sim E
Bioorg Med Chem Lett; 2013 May; 23(9):2759-64. PubMed ID: 23518278
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris.
Madikane VE; Bhakta S; Russell AJ; Campbell WE; Claridge TD; Elisha BG; Davies SG; Smith P; Sim E
Bioorg Med Chem; 2007 May; 15(10):3579-86. PubMed ID: 17368035
[TBL] [Abstract][Full Text] [Related]
7. Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
Westwood IM; Bhakta S; Russell AJ; Fullam E; Anderton MC; Kawamura A; Mulvaney AW; Vickers RJ; Bhowruth V; Besra GS; Lalvani A; Davies SG; Sim E
Protein Cell; 2010 Jan; 1(1):82-95. PubMed ID: 21204000
[TBL] [Abstract][Full Text] [Related]
8. Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophages.
Abuhammad A; Fullam E; Lowe ED; Staunton D; Kawamura A; Westwood IM; Bhakta S; Garner AC; Wilson DL; Seden PT; Davies SG; Russell AJ; Garman EF; Sim E
PLoS One; 2012; 7(12):e52790. PubMed ID: 23285185
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from
Tran HT; Solnier J; Pferschy-Wenzig EM; Kunert O; Martin L; Bhakta S; Huynh L; Le TM; Bauer R; Bucar F
Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32650510
[TBL] [Abstract][Full Text] [Related]
10. Thiazolyl-pyrazole derivatives as potential antimycobacterial agents.
Takate SJ; Shinde AD; Karale BK; Akolkar H; Nawale L; Sarkar D; Mhaske PC
Bioorg Med Chem Lett; 2019 May; 29(10):1199-1202. PubMed ID: 30910461
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
[TBL] [Abstract][Full Text] [Related]
12. Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
Westwood IM; Kawamura A; Russell AJ; Sandy J; Davies SG; Sim E
Comb Chem High Throughput Screen; 2011 Feb; 14(2):117-24. PubMed ID: 21118080
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.
Mamolo MG; Zampieri D; Falagiani V; Vio L; Banfi E
Farmaco; 2001 Aug; 56(8):593-9. PubMed ID: 11601645
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 5-(5-nitrothiophen-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazole derivatives with improved solubility and potential antituberculosis activity.
Khambete M; Kundaikar H; Raju A; Lonkar S; Degani M; Ray MK
Chem Biol Drug Des; 2019 Jan; 93(1):84-88. PubMed ID: 30142699
[TBL] [Abstract][Full Text] [Related]
15. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
[TBL] [Abstract][Full Text] [Related]
16. Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.
Solnier J; Martin L; Bhakta S; Bucar F
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046221
[TBL] [Abstract][Full Text] [Related]
17. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
18. Antimycobacterial evaluation of novel [4,5-dihydro-1H-pyrazole-1-carbonyl]pyridine derivatives synthesized by microwave-mediated Michael addition.
Sedighi V; Azerang P; Sardari S
Drug Test Anal; 2015 Jun; 7(6):550-4. PubMed ID: 25219796
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA
Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
